Contract 75D30125F20431
Zen-Bio, Inc. · Department Of Health And Human Services · January 22, 2025
Zen-Bio, Inc. was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on January 22, 2025 for $88,000 of work in biological product (except diagnostic) manufacturing. Performance is in Durham, NC. This is a task or delivery order issued under parent IDIQ 75D30123A17284. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on April 29, 2025.
Contract details
- PIID
- 75D30125F20431
- Parent IDIQ
- 75D30123A17284
- Award type
- Bpa Call
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Durham, NC
- First action
- January 22, 2025
- Latest action
- April 29, 2025
Description
BLOOD
Modification timeline
-
April 29, 2025Mod P00002$0
-
March 6, 2025Mod P00001$0
-
January 22, 2025Base award$87.6K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30125F20431?
Contract 75D30125F20431 is a federal contract awarded to Zen-Bio, Inc. by Department Of Health And Human Services on January 22, 2025 for $88,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75D30125F20431?
Zen-Bio, Inc. won contract 75D30125F20431 from Department Of Health And Human Services.
How much is contract 75D30125F20431 worth?
Contract 75D30125F20431 has obligated $88,000 to date.